Shin-jae Kim

Ulsan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.

Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.

Journal: Diabetes, obesity & metabolism
Published: April 16, 2026

Cardiorenal outcomes of empagliflozin versus dapagliflozin in primary prevention among patients with type 2 diabetes: A nationwide cohort study.

Cardiorenal outcomes of empagliflozin versus dapagliflozin in primary prevention among patients with type 2 diabetes: A nationwide cohort study.

Journal: Diabetes research and clinical practice
Published: November 05, 2025

Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study.

Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study.

Journal: Clinical therapeutics
Published: June 15, 2025

Renal function-dependent risk of early invasive strategy in patients with non-ST-segment elevation myocardial infarction: insight from KAMIR-NIH and KRAMI-RCC.

Renal function-dependent risk of early invasive strategy in patients with non-ST-segment elevation myocardial infarction: insight from KAMIR-NIH and KRAMI-RCC.

Journal: Heart and vessels
Published: March 27, 2025

Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC.

Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC.

Journal: Journal of clinical medicine
Published: June 26, 2024

Prognostic impact of beta-blocker use by N-terminal pro-brain natriuretic peptide level in acute heart failure patients.

Prognostic impact of beta-blocker use by N-terminal pro-brain natriuretic peptide level in acute heart failure patients.

Journal: ESC heart failure
Published: March 09, 2024

Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.

Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.

Journal: Epidemiology and health
Published: October 21, 2022

Unusual Case of Iatrogenic Inadvertent Diversion of the Inferior Vena Cava Into the Left Atrium in a Patient With Atrial Septal Defect: Diagnosed by the Intraoperative Transesophageal Echocardiography.

Unusual Case of Iatrogenic Inadvertent Diversion of the Inferior Vena Cava Into the Left Atrium in a Patient With Atrial Septal Defect: Diagnosed by the Intraoperative Transesophageal Echocardiography.

Journal: Journal of cardiovascular imaging
Published: February 25, 2022

An Unusual Case of Scimitar Syndrome with Drainage to the Right Atrium.

An Unusual Case of Scimitar Syndrome with Drainage to the Right Atrium.

Journal: Journal of cardiovascular imaging
Published: November 25, 2021

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.

Journal: PloS one
Published: October 20, 2021

Left Ventricular Apical Aneurysm: Atypical Feature of Cardiac Sarcoidosis Diagnosed by Multimodality Imaging.

Left Ventricular Apical Aneurysm: Atypical Feature of Cardiac Sarcoidosis Diagnosed by Multimodality Imaging.

Journal: Korean circulation journal
Published: September 07, 2021

A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension.

A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension.

Journal: Clinical therapeutics
Published: February 16, 2021
Showing 1-12 of 34

Last Updated: 09/26/2026